KassondraSuzanneGrzankowskiMDFACOG
[Pronunciation: gran-kow-ski]
Obstetrics & Gynecology • San Antonio, TXGynecologic Oncology
Physician
Dr. Grzankowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8715 Village Dr
#116
San Antonio, TX 78217- Is this information wrong?
Summary
- Dr. Kassondra Grzankowski, "Dr. G", is a Gynecologic Oncologist who provide comprehensive women's cancer care including surgery, chemotherapy, and radiation, if required, for ovarian, uterine, endometrial, cervical, vulvar, and vaginal cancers. Dr. G is a fellowship trained Gynecologic Oncologist board certified in Obstetrics and Gynecology.
Education & Training
University at BuffaloFellowship, Gynecologic Oncology, 2012 - 2016
University of HawaiiResidency, Obstetrics and Gynecology, 2008 - 2012- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
Certifications & Licensure
AZ State Medical License 2016 - 2026
NY State Medical License 2012 - 2025
TX State Medical License 2020 - 2024
HI State Medical License 2008 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- The CD47 "don't eat me signal" is highly expressed in human ovarian cancer.Brightwell RM, Grzankowski KS, Lele S, Eng K, Arshad M, Chen H, Odunsi K> ;Gynecol. Oncol.. 2016-11-01
- 3 citationsEvaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.K.S. Grzankowski, J. Brian Szender, Chandra L. Spring-Robinson, Shashikant Lele, Kunle Odunsi, Peter J. Frederick> ;International Journal of Gynecological Cancer. 2016 Oct 1
- Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.Grzankowski, K. S., Szender, J. B., Spring-Robinson, C. L., Lele, S. B., Odunsi, K. O., Frederick, P. J.> ;International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Oct 1
- Join now to see all
Press Mentions
Cervical Cancer: What You Need to KnowOctober 24th, 2017
External Links
- My Website:https://www.drggynonc.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
